Alsymo Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Alsymo General Information

Description

Operator of a drug development company intended to develop a drug for a rare, debilitating and fatal disease Pulmonary Arterial Hypertension. The company's patented active ingredient counters vascular remodeling, which is the thickening of the vessels responsible for increased blood pressure in the lungs, enabling the healthcare industry to access suitable drugs to cure Pulmonary Arterial Hypertension.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 63 Rue Gabriel Peri
  • 94270 Le Kremlin-Bicêtre
  • France
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 63 Rue Gabriel Peri
  • 94270 Le Kremlin-Bicêtre
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alsymo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jun-2023 Completed Startup
To view Alsymo’s complete valuation and funding history, request access »

Alsymo Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
SATT Paris-Saclay Accelerator/Incubator Minority
To view Alsymo’s complete investors history, request access »

Alsymo FAQs

  • When was Alsymo founded?

    Alsymo was founded in 2022.

  • Where is Alsymo headquartered?

    Alsymo is headquartered in Le Kremlin-Bicêtre, France.

  • What industry is Alsymo in?

    Alsymo’s primary industry is Biotechnology.

  • Is Alsymo a private or public company?

    Alsymo is a Private company.

  • What is Alsymo’s current revenue?

    The current revenue for Alsymo is .

  • How much funding has Alsymo raised over time?

    Alsymo has raised $709K.

  • Who are Alsymo’s investors?

    SATT Paris-Saclay has invested in Alsymo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »